Anna V. Subramaniam

Anna V. Subramaniam

Auto-generated profile, based on publicly available information

Anna V. Subramaniam

Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2022 in Circulation: Heart Failure
Verified
Journal Article
Closed access
PDF file
ASAnna V. Subramaniam
Anna V. Subramaniam
SWSusan A. Weston
Susan A. Weston
JKJill M. Killian
Jill M. Killian
PSPhillip J. Schulte
Phillip J. Schulte
VRVeronique L. Roger
Veronique L. Roger
SDShannon M. Dunlay
Shannon M. Dunlay
Background: Some patients with heart failure (HF) will go on to develop advanced HF, characterized by severe HF symptoms despite attempts to optimize medical therapy. The goals of this study were to examine the risk of developing advanced HF in patients with newly diagnosed HF, identify risk factors for developing advanced HF, and evaluate the impact of advanced HF on outcomes. Methods: This was a population-based, retrospective cohort study of Olmsted County, Minnesota, residents with a new clinical diagnosis of HF between 2007 and 2017. Risk factors for the development of advanced HF (2018 European Society of Cardiology criteria) were examined using cause-specific Cox proportional hazard regression models. The associations of development of advanced HF with risks of hospitalization and mortality were examined using the Andersen-Gill and Cox models, respectively. Results: There were 4597 residents with incident HF from 2007 to 2017. The cumulative incidence of advanced HF was 11.5% (95% CI, 10.5%–12.5%) at 6 years after incident HF diagnosis overall and was 14.4% (95% CI, 12.3%–16.9%), 11.4% (95% CI, 8.9%–14.6%), and 11.7% (95% CI, 10.3%–13.2%) in patients with incident HF with reduced, mildly reduced, and preserved ejection fraction, respectively. Key demographics, comorbidities, and echocardiographic characteristics were independently associated with the development of advanced HF. Development of advanced HF was associated with increased risks of all-cause hospitalization (adjusted hazard ratio, 3.0 [95% CI, 2.7–3.4]; P <0.001), HF hospitalization (hazard ratio, 10.2 [95% CI, 8.7–12.1]), all-cause mortality (hazard ratio, 5.0 [95% CI, 4.5–5.6]; P <0.001), and cardiovascular mortality (hazard ratio, 7.8 [95% CI, 6.7–9.1]). Conclusions: In this population-based study, development of advanced HF was common and was associated with markedly increased morbidity and mortality.

6 April 2020 in The American Journal of Cardiology
Verified
Journal Article
Closed access
Saraschandra VallabhajosyulaSaraschandra Vallabhajosyula
Saraschandra Vallabhajosyula
SPSri Harsha Patlolla
Sri Harsha Patlolla
DVDhiran Verghese
Dhiran Verghese
LYLina Ya’qoub
Lina Ya’qoub
VKVinayak Kumar
Vinayak Kumar
ADAbhishek J. Deshmukh
Abhishek J. Deshmukh

1 June 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
ASAnna V. Subramaniam
Anna V. Subramaniam
SPSri Harsha Patlolla
Sri Harsha Patlolla
Wisit CheungpasitpornWisit Cheungpasitporn
Wisit Cheungpasitporn
PSPranathi R. Sundaragiri
Pranathi R. Sundaragiri
EMElliott Miller
Elliott Miller
Saraschandra VallabhajosyulaSaraschandra Vallabhajosyula
Saraschandra Vallabhajosyula
Background: The role of race and ethnicity in the outcomes of cardiac arrest (CA) complicating acute myocardial infarction (AMI) is incompletely understood. Methods and Results: This was a retrospective cohort study of adult admissions with AMI‐CA from the National Inpatient Sample (2012–2017). Self‐reported race/ethnicity was classified as White, Black, and others (Hispanic, Asian or Pacific Islander, Native American, Other). Outcomes of interest included in‐hospital mortality, coronary angiography, percutaneous coronary intervention, palliative care consultation, do‐not‐resuscitate status use, hospitalization costs, hospital length of stay, and discharge disposition. Of the 3.5 million admissions with AMI, CA was noted in 182 750 (5.2%), with White, Black, and other races/ethnicities constituting 74.8%, 10.7%, and 14.5%, respectively. Black patients admitted with AMI‐CA were more likely to be female, with more comorbidities, higher rates of non–ST‐segment–elevation myocardial infarction, and higher neurological and renal failure. Admissions of patients of Black and other races/ethnicities underwent coronary angiography (61.9% versus 70.2% versus 73.1%) and percutaneous coronary intervention (44.6% versus 53.0% versus 58.1%) less frequently compared to patients of white race ( p <0.001). Admissions of patients with AMI‐CA had significantly higher unadjusted mortality (47.4% and 47.4%) as compared with White patients admitted (40.9%). In adjusted analyses, Black race was associated with lower in‐hospital mortality (odds ratio [OR], 0.95; 95% CI, 0.91–0.99; P =0.007) whereas other races had higher in‐hospital mortality (OR, 1.11; 95% CI, 1.08–1.15; P <0.001) compared with White race. Admissions of Black patients with AMI‐CA had longer length of hospital stay, higher rates of palliative care consultation, less frequent do‐not‐resuscitate status use, and fewer discharges to home (all P <0.001). Conclusions: Racial and ethnic minorities received less frequent guideline‐directed procedures and had higher in‐hospital mortality and worse outcomes in AMI‐CA.

24 August 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Saraschandra VallabhajosyulaSaraschandra Vallabhajosyula
Saraschandra Vallabhajosyula
ASAnna V. Subramaniam
Anna V. Subramaniam
DMDennis H. Murphree
Dennis H. Murphree
SPSri Harsha Patlolla
Sri Harsha Patlolla
LYLina Ya’qoub
Lina Ya’qoub
GBGregory W. Barsness
Gregory W. Barsness
There are limited data on the complications with a percutaneous left ventricular assist device (pLVAD) vs. intra-aortic balloon pump (IABP) in acute myocardial infarction-cardiogenic shock (AMI-CS). To assess the trends, rates and predictors of complications. Using a 17-year AMI-CS population from the National Inpatient Sample, AMI-CS admissions receiving pLVAD and IABP support were evaluated for vascular, lower limb amputation, hematologic, neurologic and acute kidney injury (AKI) complications. In-hospital mortality, hospitalization costs and length of stay in pLVAD and IABP cohorts with complications was studied. Of 168,645 admissions, 7,855 (4.7%) receiving pLVAD support. The pLVAD cohort had higher comorbidity, cardiac arrest (36.1% vs. 29.7%) and non-cardiac organ failure (74.7% vs. 56.9%) rates. Complications were higher in pLVAD compared to IABP cohort–overall 69.0% vs. 54.7%; vascular 3.8% vs. 2.1%; lower limb amputation 0.3% vs. 0.3%; hematologic 36.0% vs. 27.7%; neurologic 4.9% vs. 3.5% and AKI 55.4% vs. 39.1% (all p<0.001 except for amputation). Non-White race, higher comorbidity, organ failure, and extracorporeal membrane oxygen use were predictors of complications for both cohorts. The pLVAD cohort with complications had higher in-hospital mortality (45.5% vs. 33.1%; adjusted odds ratio 1.65 [95% confidence interval 1.55–1.75]), shorter duration of hospital stay, and higher hospitalization costs compared to the IABP cohort with complications (all p<0.001). These results were consistent in propensity-matched pairs. AMI-CS admissions receiving pLVAD had higher rates of complications compared to the IABP, with worse in-hospital outcomes in the cohort with complications.

27 July 2020 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
Saraschandra VallabhajosyulaSaraschandra Vallabhajosyula
Saraschandra Vallabhajosyula
ASAnna V. Subramaniam
Anna V. Subramaniam
PSPranathi R. Sundaragiri
Pranathi R. Sundaragiri
Wisit CheungpasitpornWisit Cheungpasitporn
Wisit Cheungpasitporn
ZTZelalem Temesgen
Zelalem Temesgen
GBGregory W. Barsness
Gregory W. Barsness
Background: There are limited data on the outcomes of acute myocardial infarction–cardiogenic shock (AMI-CS) in patients with HIV infection and AIDS.Setting: Twenty percent sample of all US hospitals.Methods: A retrospective cohort of AMI-CS during 2000–2017 from the National Inpatient Sample was evaluated for concomitant HIV and AIDS. Outcomes of interest included in-hospital mortality and use of cardiac procedures. A subgroup analysis was performed for those with and without AIDS within the HIV cohort.Results: A total 557,974 AMI-CS admissions were included, with HIV and AIDS in 1321 (0.2%) and 985 (0.2%), respectively. The HIV cohort was younger (54.1 vs. 69.0 years), more often men, of non-White race, uninsured, from a lower socioeconomic status, and with higher comorbidity (allP< 0.001). The HIV cohort had comparable multiorgan failure (37.8% vs. 39.0%) and cardiac arrest (28.7% vs. 27.4%) (P> 0.05). The cohorts with and without HIV had comparable rates of coronary angiography (70.2% vs. 69.0%;P= 0.37) but less frequent early coronary angiography (hospital day zero) (39.1% vs. 42.5%;P< 0.001). The cohort with HIV had higher unadjusted but comparable adjusted in-hospital mortality compared with those without [26.9% vs. 37.4%; adjusted odds ratio 1.04 (95% confidence interval: 0.90 to 1.21);P= 0.61]. In the HIV cohort, AIDS was associated with higher in-hospital mortality [28.8% vs. 21.1%; adjusted odds ratio 4.12 (95% confidence interval: 1.89 to 9.00);P< 0.001].Conclusions: The cohort with HIV had comparable rates of cardiac procedures and in-hospital mortality; however, those with AIDS had higher in-hospital mortality.

5 March 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
ASAnna Subramaniam
Anna Subramaniam
Demetrio Sharp DimitriDemetrio Sharp Dimitri
Demetrio Sharp Dimitri
GMG. Burkhard Mackensen
G. Burkhard Mackensen
DEDavid Elison
David Elison
CCChristine J. Chung
Christine J. Chung
JMJames M. McCabe
James M. McCabe
A 33-year-old man with unrepaired tetralogy of Fallot, Eisenmenger syndrome, and torrential aortic regurgitation secondary to previous Streptococcus mitis endocarditis (now sterilized) presented to a local hospital with recurrent decompensated heart failure. Gated computed tomography demonstrated no calcification and an annulus area of 1328 mm2. The patient’s anatomy included an overriding aorta and a large ventriculoseptal defect, allowing for antegrade delivery of a MitraClip NT, which was successfully implanted between the right and noncoronary cusps. Final transesophogeal echocardiography showed diminished aortic regurgitation with a reduction in 3-dimensional vena contracta area from 0.37 to 0.11 cm2.